VevaRX Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.2/10
Best for: patients comfortable prepaying by the quarter for a flat per-dose price
Price is where VevaRX scores best in our breakdown.
Semaglutide
Tirzepatide
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
VevaRX sells compounded semaglutide and tirzepatide as prepaid three-month programs rather than monthly subscriptions, bundling medication, supplies, provider visits and free shipping into one charge. Semaglutide is $367 per quarter and tirzepatide $467, each auto-renewing every three months with a three-month minimum. It publishes an explicit 36-state service list.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to VevaRX
Editorial score · methodology
TMates
Best for: nationwide compounded GLP-1 availability including Puerto Rico
Editorial score · methodology
Editorial score · methodology
VevaRX at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $122/mo (Site states "Same price at every dose" for this program.)
- Pricing model
- Flat — dose increases don't raise the monthly price
- What's included
- Medication · Consult · Shipping
- Availability
- 36 states
- FDA status
- No FDA warning letter on record
How we scored VevaRX
Each dimension is scored algorithmically from VevaRX’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
8.3/10At $122/mo, VevaRX runs about 28% below the $169 median for GLP-1 providers. Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
7.4/10VevaRX offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
6.7/10Online intake and platform experience — consult included in the price; 6 platform features disclosed.
Trust & Safety15%
7.4/10Key details fully confirmed by our editors; no FDA warning letters on file (last checked 2026-08-27).
Accessibility10%
6.6/10VevaRX is available in 36 states.
Support10%
5.2/10VevaRX provides standard clinician follow-up; no extended coaching or community program is disclosed.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this VevaRX review
Last checked August 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed availability in 36 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: high.
What to expect when you sign up with VevaRX
We walked VevaRX’s public signup flow in August 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Pick semaglutide or tirzepatide from the Weight Loss menu; each has its own product page.
- 2The three-month plan price, the per-month equivalent and the inclusions are all shown before intake.
- 3"Get Started" leads to the health assessment for review by a licensed provider.
- 4The walk was stopped before the health assessment collected personal or medical detail.
- Pricing is unusually explicit about being fixed in advance: "Locked in price before patient intake" and "Same price at every dose".
- The billing unit is a quarter, not a month — the per-month figure shown is an average of a single upfront charge.
- The tirzepatide per-month figure does not reconcile: $467 over three months is $155.67, not the advertised $149.
- The FAQ quotes a different entry price again — "a monthly subscription starting at $183/month" — which matches neither product page.
- The terms and conditions still carry another brand's domain, trimrx.com, in the transaction-currency clause.
- The FAQ publishes a specific 36-state list, which is more precise than most competitors' blanket claims.
VevaRX customer support
- Phone
- 714-651-9132
- info@vevarx.com
GLP-1 medications VevaRX offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Site states "Same price at every dose" for this program.
The site advertises "$149 per month" for this plan, but $467 over three months is $155.67.
Ready to get started?
Plans and promotions change often — check VevaRX's current pricing and active discounts before you decide.
What we like
- The service area is published as an explicit 36-state list rather than a blanket "all 50 states" claim.
- Price is locked before intake — the site states the quoted figure is "locked in price before patient intake".
- The quarterly charge is stated to include medication, all supplies, provider visits and free 2-3 day shipping.
- Semaglutide is priced the same at every dose, so titration does not raise the bill.
- Effective cost is competitive: $367 a quarter for semaglutide works out at about $122 a month.
- The program includes unlimited physician access and 24/7 care-team support per the FAQ.
Watch-outs
- There is no month-to-month option — a three-month minimum applies and the plan auto-renews every three months.
- The tirzepatide plan is advertised at "$149 per month" but $467 across three months is $155.67 a month.
- The terms and conditions repeatedly reference a different brand, stating "All transactions on trimrx.com are conducted in United States Dollars".
- The terms list prices ($199 and $349 first-month, $299 and $399) that match none of the prices on the product pages.
- Other product pages contradict themselves — the sermorelin page shows "$399 total" beside plan text reading "priced at $367".
- The stated governing law is circular: "the laws of the United States and the state in which VevaRx operates", and the sentence is duplicated.
- Refunds are granted only in two narrow circumstances, and the compounding pharmacy is not named.
Is VevaRX worth it? Our verdict
VevaRX positions itself around one thing: patients comfortable prepaying by the quarter for a flat per-dose price. It runs $122/month, flat across every dose — toward the affordable end of the market. Its flat, all-dose pricing is a genuine plus for anyone worried about cost climbing as they titrate up.
What gives VevaRX its own flavor: Flat Dose Pricing.
How much VevaRX actually costs
- Compounded semaglutide — $122/month
- Compounded tirzepatide — $156/month
That puts VevaRX below the roughly $169 median ongoing price across the GLP-1 providers we track — a real cost advantage.
For a direct comparison, Try Ageless runs semaglutide and tirzepatide from $119/month — worth pricing against VevaRX before you commit.
Medications: what VevaRX prescribes
VevaRX prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two molecules with the strongest published weight-loss trial outcomes. The medication is compounded at a licensed pharmacy rather than sold as a brand pen, which is what keeps the price down. The trade-off is the one every compounded provider shares: compounded drugs aren't FDA-approved as finished products.
Who VevaRX is best for — and who should skip it
A good fit if you…
- are focused on the lowest ongoing monthly cost.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen.
- need to bill insurance — like most of this market, it's cash-pay.
Trust, safety, and medical oversight
VevaRX is available in 36 states. We found no FDA warning letters on file for the provider. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
VevaRX earns its place on the shortlist mainly on price: at $122/month it's one of the more affordable ways to stay on a GLP-1, without obvious corners cut on access or oversight.
The Bottom Line
Price is where VevaRX scores best in our breakdown.
Ready to start with VevaRX?
Starting at $122/month. See current pricing and start your free consultation.
VevaRX might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this VevaRX review:
Sources & methodology — as of August 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See VevaRX's current pricing
Plans start at $122/month. Start your free consultation to check eligibility and today's price.